Psilocybin, moralization and psychotherapy: a scoping review and a case report
Philosophical Psychology – August 20, 2024
Source: OpenAlex
Summary
Psilocybin and other hallucinogens offer a profound shift in psychiatric care. Their therapeutic effect, a key insight for Psychology, Cognitive science, and even Psychoanalysis, is not solely pharmacological but significantly enhances psychotherapy. Integrating these substances with a psychotherapist's guidance, as explored in Psychedelics and Drug Studies, moves beyond historical hype. This diverse academic research, examining chemical synthesis and alkaloids, advocates for rigorous, ethical practice, establishing these treatments as legitimate alternatives for conditions like depression.
Abstract
The resurgence of interest in psychedelic substances for psychiatric treatment has sparked both excitement and scepticism within the scientific community. This paper addresses the moralisation and hype surrounding psychedelic therapies. Through a systematic review of the literature and a detailed case study, we illustrate that the therapeutic effect of psychedelics is not solely pharmacological but is instead facilitated by their ability to enhance psychotherapy. The paper explores the historical context of psychedelics in psychiatry, their mechanism of action, and evidence of their efficacy in treating depression. We highlight the necessity of integrating psychedelics with psychotherapeutic interventions and emphasise the importance of methodological rigour and ethical standards in psychedelic research and practice. By presenting an informed understanding of psychedelic treatments, we advocate for their consideration as legitimate alternatives alongside traditional therapies, offering a potential paradigm shift in psychiatric care.